FXYD6: a novel therapeutic target toward hepatocellular carcinoma

FXYD6, FXYD domain containing ion transport regulator 6, has been reported to affect the activity of Na(+)/K(+)-ATPase and be associated with mental diseases. Here, we demonstrate that FXYD6 is up-regulated in hepatocellular carcinoma (HCC) and enhances the migration and proliferation of HCC cells....

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qian, Chen, Xiongfei, Duan, Hongxia, Wang, Zhaoqing, Feng, Jing, Yang, Dongling, Song, Lina, Zhou, Ningxin, Yan, Xiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Higher Education Press 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085285/
https://www.ncbi.nlm.nih.gov/pubmed/24715268
http://dx.doi.org/10.1007/s13238-014-0045-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085285/
https://www.ncbi.nlm.nih.gov/pubmed/24715268
http://dx.doi.org/10.1007/s13238-014-0045-0

Ejemplares similares